The pharma and biotech company said it plans to use the genome editing technology in its bioproduction products and services and in stem cells for research.
Researchers were able to estimate the number of active hematopoietic stem cells based on the number of somatic mutations present.
Researchers in Japan being a new trial of induced pluripotent stem cells to treat Parkinson's disease, Science reports.
The two studies used Drop-seq RNA profiling to discover essentially all cell types and establish cell lineages in a model organism flatworm.
Kyoto University investigator has been fired for research misconduct, while Nobel Laureate Shinya Yamanaka has been penalized for lack of oversight, Retraction Watch reports.
In PNAS this week: a DNA repair map for Saccharomyces cerevisiae, an in vitro method for genetic mapping in hybrid mammals, and more.
As the California Institute for Regenerative Medicine runs out of funds, NPR asks whether states will again fund stem cell research.
A Kyoto University investigation finds a researcher guilty of manipulating image data in a stem cell paper, Retraction Watch reports.
The companies will offer CDI's human induced pluripotent stem cell-derived tissue cells with Nanion's ion channel drug discovery and screening platform.
In Nature this week: variability in iPSCs, the silver birch, and more.
The World Health Organization has announced the members of its gene-editing committee, according to NPR.
DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.
The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.
In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.